Allen Investment Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-8,174
Closed -$731K 189
2018
Q3
$731K Hold
8,174
0.03% 126
2018
Q2
$649K Hold
8,174
0.02% 126
2018
Q1
$729K Buy
8,174
+4,020
+97% +$386K 0.03% 111
2017
Q4
$434K Sell
4,154
-4,463
-52% -$504K 0.02% 133
2017
Q3
$1.26M Buy
8,617
+758
+10% +$103K 0.06% 88
2017
Q2
$1.02M Buy
7,859
+3,085
+65% +$378K 0.05% 95
2017
Q1
$594K Sell
4,774
-402
-8% -$48.1K 0.03% 131
2016
Q4
$599K Hold
5,176
0.04% 126
2016
Q3
$541K Hold
5,176
0.03% 126
2016
Q2
$511K Sell
5,176
-2,580
-33% -$267K 0.04% 133
2016
Q1
$776K Hold
7,756
0.06% 104
2015
Q4
$929K Hold
7,756
0.08% 90
2015
Q3
$839K Buy
7,756
+1,168
+18% +$145K 0.08% 105
2015
Q2
$762K Sell
6,588
-670
-9% -$76.6K 0.07% 120
2015
Q1
$837K Hold
7,258
0.06% 106
2014
Q4
$812K Buy
7,258
+2,368
+48% +$250K 0.06% 105
2014
Q3
$463K Buy
+4,890
New +$441K 0.04% 132

Other funds holding CELG

Allen Investment Management's CELG Position: Q4 2018 in Review

Allen Investment Management sold out of Celgene Corp (CELG) in Q4 2018, closing a stake of 8,174 shares — an estimated $731K sold.

Allen Investment Management first reported a position in CELG in Q3 2014 and held it in 17 quarters. The position peaked at $1.26M in Q3 2017. 1,317 funds tracked by Wall St. Rank hold CELG as of Q4 2018.

  • Allen Investment Management reported no remaining Celgene Corp position as of Q4 2018 after selling out during the quarter.
  • Allen Investment Management sold 8,174 Celgene Corp shares in Q4 2018, an estimated $731K.
  • Allen Investment Management first reported a position in Celgene Corp in Q3 2014 and held it in 17 quarters.
  • Allen Investment Management's Celgene Corp position peaked at $1.26M in Q3 2017.
  • 1,317 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2018.

Based on Allen Investment Management's 13F filing for Q4 2018, filed 5 Feb 2019.